Physician profile
Ashley E Skaggs
NPI 1790925758
$3,323.36
in general payments reported to CMS, 2019-2025
19 companies · $662 in 2025
The $662 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $524 · 2022: $459 · 2023: $791 · 2024: $887 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,339.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $800.89 | 2023-2025 | Caplyta |
| Lilly USA, LLC | $478.62 | 2021-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $430.36 | 2021-2025 | |
| Amgen INC. | $327.07 | 2021-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $293.37 | 2021-2025 | |
| Novo Nordisk INC | $235.45 | 2021-2025 | Wegovy |
| Glaxosmithkline, LLC. | $174.88 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Mylan Specialty L.P. | $103.70 | 2021-2023 | Yupelri |
| Sumitomo Pharma America, INC. | $95.90 | 2024-2025 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $90.44 | 2021-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.69 | 2021-2023 | Jardiance |
| Pfizer INC. | $47.01 | 2021 | |
| Esperion Therapeutics, INC. | $46.22 | 2021-2024 | Nexletol |
| Viatris Specialty LLC | $43.56 | 2025 | Yupelri |
| Dynavax Technologies Corporation | $26.97 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $21.91 | 2023 | Puraply |
| Merz Pharmaceuticals, LLC | $21.81 | 2023 | Xeomin |
| Bayer Healthcare Pharmaceuticals INC. | $19.18 | 2022 | |
| Exact Sciences Corporation | $16.33 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Skaggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.